New Study Shows Fungal and Bacterial Profiles in IBD Patients Predict Infliximab Response
The Journal of Crohn’s and Colitis has published a study that could lead to a new way of prescribing biologics to those suffering from IBD. Researchers have found two particular strains, one fungal the other bacterial, in the intestines of IBD patients that failed to respond to Infliximab (Remicade). Infliximab is almost always the … Read more